We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Boston Scientific to Pay $716 Mill. to J&J in Legal Settlement

By HospiMedica International staff writers
Posted on 02 Oct 2009
In a multimillion-dollar settlement, Boston Scientific (Natick, MA, USA) has agreed to compensate Johnson & Johnson (J&J; New Brunswick, NJ, USA) over patent claims.

The announced settlement, amounting to US$716 million, substantially resolves Boston Scientific's legal obligation to J&J after 12 years of lawsuits over conflicting patent claims about stents used in interventional cardiology. More...
The settlement resolves 14 lawsuits between the two companies, with possibly 3 more lawsuits remaining unsettled. The settlement also includes patents and cross-licenses between the companies.

Also pending is a court win in which Boston Scientific was favored in a patent verdict against J&J. The amount of the judgment, however, is not known at this time.

Major stent manufacturers, among them Abbott and Medtronic, have filed patent lawsuits against each other, some of which have been settled to date. Earlier in 2009, Boston Scientific has also settled a patent claim lawsuit with Medtronic.

Boston Scientific leads the stent market with $4 billion in annual sales.

Related Links:
Boston Scientific
Johnson and Johnson



Gold Member
Neonatal Heel Incision Device
Tenderfoot
Gold Member
12-Channel ECG
CM1200B
X-Ray Generator
Advantage Plus Generators
Surgical System
Stealth AXiS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Coredio’s CPSE is a a software-as-a-medical-device platform designed for use with consumer smartwatches and standard blood pressure cuffs in clinical and home settings under physician supervision (Photo courtesy of Coredio)

AI Platform Supports Noninvasive Remote Hemodynamic Monitoring in Heart Failure

Heart failure remains a leading cause of hospitalization in adults over 65, affecting more than 6.7 million people in the U.S. Clinicians often lose visibility into hemodynamic deterioration once patients... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.